Multi-institutional prospective study of nedaplatin plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens. - Wikidata - awgldk - TriplyDB

Multi-institutional prospective study of nedaplatin plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens.

Multi-institutional prospective study of nedaplatin plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens.

http://www.wikidata.org/entity/Q33439361

about

Clinicopathological and prognostic significance of circulating tumor cells in patients with head and neck cancer: a meta-analysis.A retrospective study of concurrent chemoradiotherapy plus S-1 adjuvant chemotherapy on curative effect for treatment of patients with N3 stage nasopharyngeal carcinoma.

P2860

Q41348062-3AD902C4-5B84-4E82-92CB-38761A2205DB Q55515841-36AA5736-15AA-4A0E-9912-1FAD403B4008

P2860

Multi-institutional prospective study of nedaplatin plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens.

http://www.wikidata.org/entity/Q33439361

description

2016 nî lūn-bûn

@nan

2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

name

Multi-institutional prospectiv ...... platinum-containing regimens.

@ast

Multi-institutional prospectiv ...... platinum-containing regimens.

@en

type

label

Multi-institutional prospectiv ...... platinum-containing regimens.

@ast

Multi-institutional prospectiv ...... platinum-containing regimens.

@en

prefLabel

Multi-institutional prospectiv ...... platinum-containing regimens.

@ast

Multi-institutional prospectiv ...... platinum-containing regimens.

@en

P1433

Q33439361-3BEA5A97-F364-462C-87F6-C5875BDFA43A

P1476

Q33439361-19BB1CD3-AE49-4968-BD20-1A7170434340

P2093

Q33439361-01C625D0-7803-46B1-AD6B-46E1B44C9D4A

Q33439361-4DED8140-BD36-41A0-A74C-217E46EB3516

Q33439361-5ADA26D0-341F-45BC-8439-12AA214354DE

Q33439361-B3C90C28-A34A-4514-92FB-349413B09694

Q33439361-B8C5FA09-0346-4FB6-BD7F-C08F6BCD02C6

Q33439361-C93D6EBE-6E9A-4D96-9AE7-A0A023290F47

Q33439361-D47002BA-AF73-4630-AA01-88630FD92DF1

Q33439361-DF41BD10-1DFC-4653-B81E-13E79F7DA8D4

P2860

Q33439361-0A36B3B7-25AF-440A-8D0E-A23CD7686EDF

Q33439361-1F276BBC-6FA8-451F-9744-BFC3E5F0DD96

Q33439361-242D43AE-22BB-471E-A729-71C4139523E3

Q33439361-34DC56DC-7341-4A39-85AA-166EB307CEE4

Q33439361-41495CFC-96F0-4F5B-BA22-48F0A3B8EB65

Q33439361-6DE7D22F-54AE-47B1-A1D7-604950435D29

Q33439361-823191A5-2C5B-4910-B5AB-CC78596D2882

Q33439361-8CD4E218-3489-4997-B755-7F810DCE8A58

Q33439361-ACF86E34-3832-438C-A9E2-E3A074F35D99

Q33439361-B02C2362-3221-4D8E-85D2-8598EAD53553

P304

Q33439361-D41051AC-C045-4755-B91F-7B44F74EA6B5

P31

Q33439361-BD27D40E-9DBB-4E39-B1ED-6D8C7DE7A621

P356

Q33439361-1E11BE2B-8CBE-45B8-8E39-F93502C3901A

P407

Q33439361-2a2f56fd-429f-4a7d-556c-41b7f1426d08

P433

Q33439361-C13A2A8B-E52F-472E-A464-9FEFFAC3D5FE

P478

Q33439361-1CEAFBC1-2EBB-423C-8FAA-ECBED8E73BF5

P577

Q33439361-5467F997-D6C3-4BFE-A5A6-52CFC09FD1FD

P5875

Q33439361-73a97592-47c8-8828-64b6-b62566337ae5

P698

Q33439361-B6D7E159-F487-4CBD-AEF5-22D341ECA75A

P921

Q33439361-cc732aa7-41c8-9c54-05ef-93a046e3000c

P932

Q33439361-C63918FA-6D16-4FFD-A327-EB0357DE92FA

P356

1758834016675099

P1433

Therapeutic advances in medical oncology

P1476

Multi-institutional prospectiv ...... platinum-containing regimens.

@en

P2093

Bao-Jun Lv

http://www.w3.org/2001/XMLSchema#string

Hai Liao

http://www.w3.org/2001/XMLSchema#string

Pei-Jian Peng

http://www.w3.org/2001/XMLSchema#string

Pei-Yu Huang

http://www.w3.org/2001/XMLSchema#string

Yu-Meng Liu

http://www.w3.org/2001/XMLSchema#string

Yun-Yan Con

http://www.w3.org/2001/XMLSchema#string

Zhi-Hui Wang

http://www.w3.org/2001/XMLSchema#string

Zhong Lin

http://www.w3.org/2001/XMLSchema#string

P2860

Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinoma.

Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma.

Pharmacokinetics of (glycolate-0,0')-diammine platinum (II), a new platinum derivative, in comparison with cisplatin and carboplatin.

The prevalence and prevention of nasopharyngeal carcinoma in China.

Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal type.

Safety and efficacy of S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy: multi-institutional retrospective analysis.

The modulated oral fluoropyrimidine prodrug S-1, and its use in gastrointestinal cancer and other solid tumors.

New options for outpatient chemotherapy--the role of oral fluoropyrimidines.

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial.

Recent perspectives in the role of chemotherapy in the management of advanced nasopharyngeal carcinoma.

P304

68-74

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1758834016675099

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

309654343

http://www.w3.org/2001/XMLSchema#string

P698

28203299

http://www.w3.org/2001/XMLSchema#string

P921

P932

5298400

http://www.w3.org/2001/XMLSchema#string